HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jun, S. Articles by Pascual, D. W. Search for Related Content PubMed PubMed Citation Articles by Jun, S. Articles by Pascual, D. W. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Diarrhea E. Coli Infections

A Live Diarrheal Vaccine Imprints a Th2 Cell Bias and Acts as an Anti-Inflammatory Vaccine¹

SangMu Jun^*, Wendy Gilmore, Gayle Callis^*, Agnieszka Rynda^*, Asmahan Haddad^* and David W. Pascual^2,*

^* Veterinary Molecular Biology, Montana State University, Bozeman, MT 59717; and Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033

An experimental vaccine for enterotoxigenic Escherichia coli (ETEC) composed of a live, attenuated Salmonella vector-expressing enterotoxigenic E. coli fimbriae, colonization factor Ag I (CFA/I), stimulated a biphasic Th cell response when given orally and suppressed the normally produced proinflammatory response. Such suppression was also evident upon the Salmonella-CFA/I infection of macrophages resulting in diminished TNF-, IL-1, and IL-6 production and suggesting that the CFA/I fimbrial expression by Salmonella may protect against a proinflammatory disease. To test this hypothesis, SJL/J mice were vaccinated with Salmonella-CFA/I construct 1 or 4 wk before induction of experimental autoimmune encephalomyelitis using an encephalitogenic proteolipid protein peptide, PLP_139–151. Mice receiving Salmonella-CFA/I vaccine recovered completely from mild acute clinical disease and showed only mild inflammatory infiltrates in the spinal cord white and gray matter. This protective effect was accompanied by a loss of encephalitogenic IFN--secreting Th cells and was replaced with an increase in IL-4, IL-10, and IL-13 secretion. Collectively, these data suggested that Salmonella-CFA/I is an anti-inflammatory vaccine that down-regulates proinflammatory cells and confers protection against a proinflammatory disease, experimental autoimmune encephalomyelitis, via immune deviation.

Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 6251-6252. [Full Text]  

This article has been cited by other articles:

				K. Z. Long, J. L. Rosado, J. I. Santos, M. Haas, A. Al Mamun, H. L. DuPont, N. N. Nanthakumar, and T. Estrada-Garcia Associations between Mucosal Innate and Adaptive Immune Responses and Resolution of Diarrheal Pathogen Infections Infect. Immun., March 1, 2010; 78(3): 1221 - 1228. [Abstract] [Full Text] [PDF]

				J. Ochoa-Reparaz, D. W. Mielcarz, L. E. Ditrio, A. R. Burroughs, D. M. Foureau, S. Haque-Begum, and L. H. Kasper Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., November 15, 2009; 183(10): 6041 - 6050. [Abstract] [Full Text] [PDF]

				I. Kochetkova, T. Trunkle, G. Callis, and D. W. Pascual Vaccination without Autoantigen Protects against Collagen II-Induced Arthritis via Immune Deviation and Regulatory T Cells J. Immunol., August 15, 2008; 181(4): 2741 - 2752. [Abstract] [Full Text] [PDF]

				J. Ochoa-Reparaz, A. Rynda, M. A. Ascon, X. Yang, I. Kochetkova, C. Riccardi, G. Callis, T. Trunkle, and D. W. Pascual IL-13 Production by Regulatory T Cells Protects against Experimental Autoimmune Encephalomyelitis Independently of Autoantigen J. Immunol., July 15, 2008; 181(2): 954 - 968. [Abstract] [Full Text] [PDF]

				A. Rynda, M. Maddaloni, D. Mierzejewska, J. Ochoa-Reparaz, T. Maslanka, K. Crist, C. Riccardi, B. Barszczewska, K. Fujihashi, J. R. McGhee, et al. Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein {sigma}1 J. Immunol., April 15, 2008; 180(8): 5187 - 5200. [Abstract] [Full Text] [PDF]

				A. Daley, R. Randall, M. Darsley, N. Choudhry, N. Thomas, I. R Sanderson, N. M Croft, and P. Kelly Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation Gut, November 1, 2007; 56(11): 1550 - 1556. [Abstract] [Full Text] [PDF]

				E. C. Boyle, J. L. Bishop, G. A. Grassl, and B. B. Finlay Salmonella: from Pathogenesis to Therapeutics J. Bacteriol., March 1, 2007; 189(5): 1489 - 1495. [Full Text] [PDF]

				J. Ochoa-Reparaz, C. Riccardi, A. Rynda, S. Jun, G. Callis, and D. W. Pascual Regulatory T Cell Vaccination without Autoantigen Protects against Experimental Autoimmune Encephalomyelitis J. Immunol., February 1, 2007; 178(3): 1791 - 1799. [Abstract] [Full Text] [PDF]

				X. Yang, B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, et al. Oral Vaccination with Salmonella Simultaneously Expressing Yersinia pestis F1 and V Antigens Protects against Bubonic and Pneumonic Plague J. Immunol., January 15, 2007; 178(2): 1059 - 1067. [Abstract] [Full Text] [PDF]